Literature DB >> 15338180

The use of neoadjuvant chemotherapy to achieve complete surgical resection in recurring supratentorial anaplastic ependymoma.

Elvis Terci Valera1, Helio Rubens Machado, Antonio Carlos Santos, Ricardo Santos de Oliveira, David Araújo, Luciano Neder, Luiz Gonzaga Tone.   

Abstract

INTRODUCTION: Ependymoma is a central nervous system neoplasm that is often managed with surgery and radiotherapy. The benefits of chemotherapy in treating this tumor remain poorly defined. CASE REPORT: The use of a platinum-based chemotherapy as a neoadjuvant treatment to permit complete surgical resection of a supratentorial anaplastic ependymoma recurring for the third time is described. DISCUSSION: This paper also discusses the possible use of chemotherapy as a strategy that may allow tumor shrinkage and ease tumor resection in giant recurring ependymomas.

Entities:  

Mesh:

Year:  2004        PMID: 15338180     DOI: 10.1007/s00381-004-0998-z

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  13 in total

1.  Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide.

Authors:  M C Chamberlain
Journal:  Pediatr Neurol       Date:  2001-02       Impact factor: 3.372

2.  Prognostic relevance of localization and grading in intracranial ependymomas of childhood.

Authors:  R I Ernestus; R Schröder; H Stützer; N Klug
Journal:  Childs Nerv Syst       Date:  1996-09       Impact factor: 1.475

3.  Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group.

Authors:  G Perilongo; M Massimino; G Sotti; T Belfontali; L Masiero; L Rigobello; L Garrè; M Carli; F Lombardi; C Solero; L Sainati; V Canale; A B del Prever; F Giangaspero; L Andreussi; C Mazza; E Madon
Journal:  Med Pediatr Oncol       Date:  1997-08

4.  A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors.

Authors:  B Horn; R Heideman; R Geyer; I Pollack; R Packer; J Goldwein; T Tomita; P Schomberg; J Ater; L Luchtman-Jones; K Rivlin; K Lamborn; M Prados; A Bollen; M Berger; G Dahl; E McNeil; K Patterson; D Shaw; M Kubalik; C Russo
Journal:  J Pediatr Hematol Oncol       Date:  1999 May-Jun       Impact factor: 1.289

Review 5.  Chemotherapy for intracranial ependymomas.

Authors:  E Bouffet; N Foreman
Journal:  Childs Nerv Syst       Date:  1999-10       Impact factor: 1.475

6.  High response rate to cisplatin/etoposide regimen in childhood low-grade glioma.

Authors:  Maura Massimino; Filippo Spreafico; Graziella Cefalo; Riccardo Riccardi; John David Tesoro-Tess; Lorenza Gandola; Daria Riva; Antonio Ruggiero; Laura Valentini; Elena Mazza; Lorenzo Genitori; Concezio Di Rocco; Piera Navarria; Michela Casanova; Andrea Ferrari; Roberto Luksch; Monica Terenziani; Maria Rosa Balestrini; Cesare Colosimo; Franca Fossati-Bellani
Journal:  J Clin Oncol       Date:  2002-10-15       Impact factor: 44.544

7.  Chemotherapy for advanced CNS ependymoma.

Authors:  M K Gornet; J C Buckner; R S Marks; B W Scheithauer; B J Erickson
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

8.  The use of chemotherapy to facilitate surgical resection in pleomorphic xanthoastrocytoma: experience in a single case.

Authors:  M Cartmill; M Hewitt; D Walker; J Lowe; T Jaspan; J Punt
Journal:  Childs Nerv Syst       Date:  2001-09       Impact factor: 1.475

Review 9.  Ependymoma.

Authors:  Charles Teo; Peter Nakaji; Patricia Symons; Vivienne Tobias; Richard Cohn; Robert Smee
Journal:  Childs Nerv Syst       Date:  2003-05-22       Impact factor: 1.475

Review 10.  Prognosis of ependymoma.

Authors:  D Schiffer; M T Giordana
Journal:  Childs Nerv Syst       Date:  1998-08       Impact factor: 1.475

View more
  6 in total

Review 1.  Salvage chemotherapy for metastatic and recurrent ependymoma of childhood.

Authors:  Eric Bouffet; Michael Capra; Ute Bartels
Journal:  Childs Nerv Syst       Date:  2009-04-10       Impact factor: 1.475

2.  Chemotherapy alleviates subacute recurrent glioma-associated refractory cerebral edema by downregulating vascular endothelial growth factor.

Authors:  Hai-long Li; Xiang-li Cui; Jian-ning Zhang; Song Lin
Journal:  Med Oncol       Date:  2014-05-27       Impact factor: 3.064

3.  Brain surface reformatted imaging (BSRI) in surgical planning for resections around eloquent cortex.

Authors:  David Araújo; Hélio Rubens Machado; Ricardo Santos Oliveira; Vera Terra-Bustamante; Dráulio Barros de Araújo; Antônio Carlos Santos; Américo Ceiki Sakamoto
Journal:  Childs Nerv Syst       Date:  2006-05-04       Impact factor: 1.475

Review 4.  WHO Grade II and III supratentorial hemispheric ependymomas in adults: case series and review of treatment options.

Authors:  Toba N Niazi; Elizabeth M Jensen; Randy L Jensen
Journal:  J Neurooncol       Date:  2008-11-01       Impact factor: 4.130

5.  Cortical anaplastic ependymoma with significant desmoplasia: a case report and literature review.

Authors:  Alaa Eldin Elsharkawy; Raid Abuamona; Markus Bergmann; Shadi Salem; Evariste Gafumbegete; Ernst Röttger
Journal:  Case Rep Oncol Med       Date:  2013-12-16

6.  World Health Organization Grade III Supratentorial Extraventricular Ependymomas in Adults: Case Series and Review of Treatment Modalities.

Authors:  Fotios Kalfas; Claudia Scudieri
Journal:  Asian J Neurosurg       Date:  2019-11-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.